Download for free the International Guidelines App.
Available in English, French, Spanish, Portuguese and Russian version.

Engage in 3 different modules on Cancer Associated Thrombosis where experts from around the world discuss the prevention of VTE in patients with cancer, how to treat cancer associated VTE and the treatment of catheter-related thrombosis.
Attend the ISTH 2021 virtual Congress to experience the latest science in thrombosis and hemostasis. You will interact with the global hematology experts and advance your knowledge and career.

Venous Thromboembolism and Cancer
A New Focus for Better Patient Outcomes

The International Initiative on Thrombosis and Cancer (ITAC), the international section of the Groupe Francophone Thrombose et Cancer (GFTC), presents this educational platform for specialist physicians and nurses involved in the care of patients with cancer who are at risk of venous thromboembolism (VTE) or with established VTE, including central venous catheter-related thrombosis (CRT).

Learn more about ITAC-CME

Moving the Needle:

Cancer Associated Thrombosis

Friday, March 12, 2021

The International Society on Thrombosis and Haemostasis (ISTH) and the International Initiative on Thrombosis and Cancer (ITAC-CME) announce the launch of new educational modules “Moving the Needle: Cancer Associated Thrombosis”. The series includes three distinct modules addressing: Primary Prophylaxis (Module 1), Module 2: Non-CRT VTE (Module 2), and Module 3: CRT VTE (Module 3).

Join Dominique Farge-Bancel, MD, Jean M. Connors, MD, and James Douketis, MD, FRCPC, FACP, FCCP, FCAHS as they provide education to hematologists and oncologists to support guideline-recommended care of patients with cancer, specifically related to appropriate VTE prophylaxis and patient-centered, individualized VTE treatment.

The program can be accessed on the ISTH Academy website in partnership withThe France Foundation

Scientific Societies